Researchers receive funding to develop 'organs-on-chips'

Researchers from several universities are working together to develop human “organs-on-chips” after receiving millions in funding.

The Ulsan National Institute of Science and Technology (UNIST) and University of Ulsan in South Korea recently announced a research collaboration to develop organs-on-chips in an effort to reduce new drug discovery costs. Organs-on-chips were described as “miniature devices that recreate the natural physiological microenvironment of human cells within specific tissues and organs.”

“These devices can help study how drugs interact with specific human organs and have the potential to predict the activity and toxicity of drugs better than using animal models. Each organ-on-a-chip can then be linked to others to investigate systemic drug effects,” a press release said.

The research initiative is happening thanks to millions in funding from the South Korean government and several universities.

The UNIST-WFIRM-UniBasel Organ Mimetic Research Center will receive 3.3 billion KRW ($2.9 million) in funding from the South Korean government over the next six years for the research project.

The University of Ulsan will contribute a total of 600 million KRW ($533,367); the Wake Forest Institute for Regenerative Medicine will contribute $3.3 million; and the University of Basel will contribute $2.97 million.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”